Blue Biofuels (BIOF) Ratios
Blue Biofuels Ratios
BIOF's free cash flow for Q2 2026 was $-292.70K. For the 2026 fiscal year, BIOF's free cash flow was decreased by $-23.88K and operating cash flow was $-268.82K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.03 | 0.04 | 0.05 | 0.40 | 2.44 |
| Quick Ratio | 0.03 | 0.04 | 0.05 | 0.40 | 2.44 |
| Cash Ratio | 0.02 | 0.02 | 0.03 | 0.33 | 2.35 |
| Solvency Ratio | -0.53 | -0.31 | -0.62 | -1.10 | -0.62 |
| Operating Cash Flow Ratio | -0.28 | -0.45 | -1.06 | -3.19 | -4.97 |
| Short-Term Operating Cash Flow Coverage | 0.00 | -20.07 | -4.57 | -40.72 | -49.30 |
| Net Current Asset Value | $ -5.04M | $ -4.15M | $ -4.51M | $ -3.21M | $ -2.02M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 1.57 | 1.54 | 3.42 | 2.76 | 1.56 |
| Debt-to-Equity Ratio | -0.60 | -0.75 | -0.99 | -1.30 | -2.05 |
| Debt-to-Capital Ratio | -1.47 | -3.04 | -95.33 | 4.37 | 1.95 |
| Long-Term Debt-to-Capital Ratio | -0.98 | -1.38 | -6.53 | 6.04 | 2.04 |
| Financial Leverage Ratio | -0.38 | -0.49 | -0.29 | -0.47 | -1.32 |
| Debt Service Coverage Ratio | -145.82 | -10.79 | -6.12 | -47.77 | -23.96 |
| Interest Coverage Ratio | -151.78 | -62.80 | -32.63 | -133.71 | -64.31 |
| Debt to Market Cap | 0.03 | 0.05 | 0.14 | 0.07 | 0.04 |
| Interest Debt Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Net Debt to EBITDA | -0.60 | -1.69 | -1.27 | -0.75 | -0.84 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 77.38% | 34.98% | 95.74% | 100.71% | 98.48% |
| Return on Assets (ROA) | -204.25% | -102.12% | -296.54% | -358.07% | -116.36% |
| Return on Equity (ROE) | 77.56% | 49.86% | 85.79% | 168.02% | 153.22% |
| Return on Capital Employed (ROCE) | 235.58% | 493.24% | 674.70% | -841.61% | -161.84% |
| Return on Invested Capital (ROIC) | 248.05% | 576.40% | 8632.02% | -642.10% | -148.32% |
| Return on Tangible Assets | -266.77% | -130.00% | -393.97% | -448.06% | -127.06% |
| Earnings Yield | -4.85% | -4.20% | -12.46% | -9.81% | -3.19% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.94 | 0.52 | 2.27 | 3.73 | 1.57 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -387.64 | -698.04 | -160.74 | -97.89 | -232.02 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 387.64 | 698.04 | 160.74 | 97.89 | 232.02 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.00 | -0.00 | -0.01 | -0.01 | -0.01 |
| Free Cash Flow Per Share | -0.00 | -0.00 | -0.01 | -0.01 | -0.01 |
| Dividend Paid and CapEx Coverage Ratio | -12.26 | -14.10 | -4.99 | -9.91 | -10.57 |
| Capital Expenditure Coverage Ratio | -12.26 | -14.10 | -4.99 | -9.91 | -10.57 |
| Operating Cash Flow Coverage Ratio | -0.38 | -0.47 | -0.45 | -0.67 | -0.86 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -1.54% | -3.18% | -7.83% | -5.55% | -4.02% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -20.65 | -23.64 | -8.03 | -10.20 | -31.39 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | -16.01 | -11.86 | -6.89 | -17.13 | -48.09 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -64.90 | -31.42 | -12.77 | -18.01 | -24.88 |
| Price-to-Operating Cash Flow Ratio | -70.20 | -33.64 | -15.32 | -19.83 | -27.24 |
| Price-to-Earnings Growth (PEG) Ratio | -0.22 | 0.44 | 0.28 | -0.13 | 2.83 |
| Enterprise Value Multiple | -17.22 | -29.01 | -10.22 | -11.40 | -34.30 |
| Enterprise Value | 61.46M | 35.85M | 28.00M | 43.22M | 68.84M |
| EV to EBITDA | -17.22 | -29.01 | -10.22 | -11.40 | -34.30 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -67.25 | -33.36 | -14.58 | -19.28 | -25.51 |
| EV to Operating Cash Flow | -72.73 | -35.73 | -17.50 | -21.23 | -27.92 |
| Tangible Book Value Per Share | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Shareholders’ Equity Per Share | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | -0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.01 | -0.00 | -0.01 | -0.01 | -0.01 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 0.77 | 1.05 | 1.03 | 1.01 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.29 | 0.71 | 0.52 | 0.51 | 1.15 |
Currency in USD
